Sarepta Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
1.741.541.261.12
Price/Sales ratio
0.550.460.390.37
Earnings per Share (EPS)
$11.34$12.79$15.67$17.55

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.26-7.41-4.99-64.56-19.97-13.28-23.98-17.47-16.12-16.62-16.06-19.97
Price/Sales ratio
59.361.30K246.3221.1724.0124.9424.6010.4212.167.1612.1124.94
Price/Book Value ratio
2.338.573.964.147.0011.6117.447.8829.4710.3629.367.00
Price/Cash Flow ratio
-4.50-10.91-5.43-14.10-18.60-20.81123.67-16.51-34.87-17.78-34.74-20.81
Price/Free Cash Flow ratio
-3.72-10.57-5.28-12.92-15.95-18.29526.07-15.19-31.85-15.14-31.73-18.29
Price/Earnings Growth ratio
-1.76-0.13-0.890.76-0.03-0.170.890.63-0.280.590.24-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-864.46%-11567.51%97.60%95.24%88.64%85.14%88.26%86.17%84.99%87.90%84.99%85.14%
Operating Profit Margin
-1371.21%-17572.54%-4920.30%-111.03%-114.14%-137.15%-104.45%-64.07%-57.46%-21.54%-57.46%-114.14%
Pretax Profit Margin
-1391.70%-17560.25%-4930.17%-31.45%-120.45%-187.45%-102.40%-59.68%-73.95%-41.83%-73.95%-120.45%
Net Profit Margin
-1391.70%-17560.25%-4930.17%-32.78%-120.22%-187.76%-102.59%-59.66%-75.39%-43.10%-75.39%-120.22%
Effective Tax Rate
1.24%2.38%2.85%-4.23%0.19%-0.16%-0.19%0.04%-1.96%-3.05%-1.96%-0.16%
Return on Assets
-46.02%-80.36%-63.01%-3.87%-22.04%-39.22%-18.56%-13.30%-22.48%-16.41%-22.48%-39.22%
Return On Equity
-54.83%-115.59%-79.37%-6.42%-35.06%-87.39%-72.74%-45.12%-182.74%-62.37%-117.29%-87.39%
Return on Capital Employed
-51.82%-104.11%-76.49%-14.07%-23.40%-33.52%-21.96%-16.68%-21.37%-10.25%-21.37%-23.40%
Liquidity Ratios
Current Ratio
6.723.604.9513.908.215.545.97N/AN/AN/A4.125.54
Quick Ratio
5.813.174.7812.967.484.905.415.343.793.453.554.90
Cash ratio
1.991.281.626.782.133.153.614.671.560.651.563.15
Days of Sales Outstanding
90.381.15K352.0069.5759.4687.1091.5889.25101.59129.0883.9659.46
Days of Inventory outstanding
129.8067.0935.97K4.15K1.33K1.10K1.33K700.34531.81783.83531.811.10K
Operating Cycle
220.181.22K36.32K4.21K1.39K1.19K1.42K789.59633.41912.91552.511.19K
Days of Payables Outstanding
48.1250.5183.36K420.29361.11439.23639.73288.62249.97400.38249.97439.23
Cash Conversion Cycle
172.051.17K-47.03K3.79K1.03K753.32787.65500.97383.43512.52-34.88753.32
Debt Ratios
Debt Ratio
0.020.080.030.320.250.370.330.340.490.380.870.25
Debt Equity Ratio
0.020.120.040.540.400.831.301.184.011.467.120.40
Long-term Debt to Capitalization
0.010.070.010.340.280.450.560.540.800.560.800.28
Total Debt to Capitalization
0.020.100.040.350.280.450.560.540.800.59N/A0.45
Interest Coverage Ratio
N/AN/AN/A-24.28-10.25-17.03-9.41N/AN/AN/A-16.84-17.03
Cash Flow to Debt Ratio
-20.31-6.38-15.22-0.53-0.92-0.660.10-0.40-0.21-0.39N/A-0.92
Company Equity Multiplier
1.191.431.251.651.592.223.913.398.123.798.121.59
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-13.17-119.28-45.34-1.50-1.29-1.190.19-0.63-0.34-0.40-0.34-1.29
Free Cash Flow / Operating Cash Flow Ratio
1.201.031.021.091.161.130.231.081.091.171.091.13
Cash Flow Coverage Ratio
-20.31-6.38-15.22-0.53-0.92-0.660.10-0.40-0.21-0.39N/A-0.92
Short Term Coverage Ratio
-49.62-17.73-24.31-37.57N/AN/AN/AN/AN/A-4.06N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A